Phenobarbital for the treatment of epilepsy in the 21st century: a critical review (Q34343308)

1 August 2017

1 reference

title

Phenobarbital for the treatment of epilepsy in the 21st century: a critical review (English)

1 reference

1 August 2017

2

Martin J Brodie

0 references

Patrick Kwan

object named as

Patrick Kwan

series ordinal

1

0 references

author name string

Martin J Brodie

series ordinal

2

1 reference

1 August 2017

publication date

1 September 2004

1 reference

1 August 2017

1 reference

1 August 2017

volume

45

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

1141-1149

1 reference

Management of epilepsy in adolescents and adults.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Global Campaign Against Epilepsy:the treatment gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Barbiturate regulation of kinetic properties of the GABAA receptor channel of mouse spinal neurones in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Seizures during barbiturate withdrawal: relation to blood level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Does withdrawal of different antiepileptic drugs have different effects on seizure recurrence? Further results from the MRC Antiepileptic Drug Withdrawal Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Genetic susceptibility to adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

P-hydroxylation of phenobarbital: relationship to (S)-mephenytoin hydroxylation (CYP2C19) polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Mechanisms of antiepileptic drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

The importance of drug interactions in epilepsy therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Inhibition of phenobarbitone N-glucosidation by valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

A Mechanistic Approach to Antiepileptic Drug Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Phenobarbital-elicited activation of nuclear receptor CAR in induction of cytochrome P450 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Growth hormone deficiency (GHD) from birth to 2 years of age: diagnostic specifics of GHD during the early phase of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Difficulties in extrapolating from clinical trial data to clinical practice: The case of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Can randomised trials inform clinical decisions about individual patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Measuring the efficacy of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Epilepsy in children in Benin City, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Neuropsychological effects of epilepsy and antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Comparative cognitive effects of anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Effectiveness of first antiepileptic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Leptin in Relation to Hepatocellular Carcinoma in Patients with Liver Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Pharmacogenetics goes genomic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.0013-9580.2004.12704.X

10.1111/J.0013-9580.2004.12704.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference